Cargando…

ROX index to predict CPAP outcome in hypoxemic respiratory failure due to COVID-19

Detalles Bibliográficos
Autores principales:	Colaianni-Alfonso, Nicolás, Montiel, Guillermo Cesar, Castro-Sayat, Mauro, Roca, Oriol, Grieco, Domenico Luca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589769/ https://www.ncbi.nlm.nih.gov/pubmed/36271184 http://dx.doi.org/10.1007/s00134-022-06913-9

Ejemplares similares

COVID-19 Pneumonia and ROX index: Time to set a new threshold for patients admitted outside the ICU
por: Vega, María Laura, et al.
Publicado: (2022)

Helmet vs Facemask CPAP in COVID-19 Respiratory Failure: A Prospective Cohort Study
por: Colaianni-Alfonso, Nicolás, et al.
Publicado: (2023)

Expanding the utility of the ROX index among patients with acute hypoxemic respiratory failure
por: Li, Andrew, et al.
Publicado: (2022)

Correction: Expanding the utility of the ROX index among patients with acute hypoxemic respiratory failure
por: Li, Andrew, et al.
Publicado: (2023)

Prognostic Performance of Bedside Lung Ultrasound Score (LUSS) and ROX Index in Hypoxemic Respiratory Failure Due to COVID-19
por: Nova, Alice, et al.
Publicado: (2023)

Role of PEEP on the prognostic performance of the ROX index in hypoxemic respiratory failure due to COVID-19: any further gain in outcome prediction?
por: Nova, Alice, et al.
Publicado: (2023)

COVID-19 pneumonia and ROX index: Time to set a new threshold for patients admitted outside the ICU. Authors' reply
por: Vega, M.L., et al.
Publicado: (2021)

Personalized noninvasive respiratory support for acute hypoxemic respiratory failure
por: Grieco, Domenico Luca, et al.
Publicado: (2023)

Continuous positive airway pressure (CPAP) as a ceiling of care treatment for hypoxemic respiratory failure due to COVID-19
por: Bradley, Patrick, et al.
Publicado: (2021)

Utility of the ROX Index in Predicting Intubation for Patients With COVID-19–Related Hypoxemic Respiratory Failure Receiving High-Flow Nasal Therapy: Retrospective Cohort Study
por: Patel, Maulin, et al.
Publicado: (2021)

The ROX index as a predictor of high-flow nasal cannula outcome in pneumonia patients with acute hypoxemic respiratory failure: a systematic review and meta-analysis
por: Zhou, Xiaoyang, et al.
Publicado: (2022)

ROX index as a good predictor of high flow nasal cannula failure in COVID-19 patients with acute hypoxemic respiratory failure: A systematic review and meta-analysis
por: Prakash, Jay, et al.
Publicado: (2021)

ROX index versus HACOR scale in predicting success and failure of high-flow nasal cannula in the emergency department for patients with acute hypoxemic respiratory failure: a prospective observational study
por: Praphruetkit, Nattakarn, et al.
Publicado: (2023)

Peer Review of “Utility of the ROX Index in Predicting Intubation for Patients With COVID-19–Related Hypoxemic Respiratory Failure Receiving High-Flow Nasal Therapy: Retrospective Cohort Study”
por: Roy, Archisman
Publicado: (2021)

Peer Review of “Utility of the ROX Index in Predicting Intubation for Patients With COVID-19–Related Hypoxemic Respiratory Failure Receiving High-Flow Nasal Therapy: Retrospective Cohort Study”
por: Sehgal, Mukul
Publicado: (2021)

Clinical and biochemical short-term effects of hyperbaric oxygen therapy on SARS-Cov-2+ hospitalized patients with hypoxemic respiratory failure
por: Keller, Guillermo A., et al.
Publicado: (2023)

Helmet CPAP to Treat Acute Hypoxemic Respiratory Failure in Patients with COVID-19: A Management Strategy Proposal
por: Radovanovic, Dejan, et al.
Publicado: (2020)

Advantages and limitations of the ROX index
por: Gallardo, A., et al.
Publicado: (2022)

Authors’ Responses to Peer Reviews of “Utility of the ROX Index in Predicting Intubation for Patients With COVID-19–Related Hypoxemic Respiratory Failure Receiving High-Flow Nasal Therapy: Retrospective Cohort Study”
por: Patel, Maulin, et al.
Publicado: (2021)

Helmet CPAP versus Oxygen Therapy in Hypoxemic Acute Respiratory Failure: A Meta-Analysis of Randomized Controlled Trials
por: Luo, Yuwen, et al.
Publicado: (2016)

Success or Failure of High-Flow Nasal Oxygen Therapy: The ROX Index Is Good, but a Modified ROX Index May Be Better
por: Karim, Habib M. R., et al.
Publicado: (2019)

Non-invasive ventilation for acute hypoxemic respiratory failure, including COVID-19
por: Rosà, Tommaso, et al.
Publicado: (2022)

ROX INDEX A PROMISING NONINVASIVE INDEX
por: PATIL, SARANG
Publicado: (2021)

Prediction of outcome of nasal high flow use during COVID-19-related acute hypoxemic respiratory failure
por: Zucman, Noémie, et al.
Publicado: (2020)

Non-invasive ventilation in the treatment of early hypoxemic respiratory failure caused by COVID-19: considering nasal CPAP as the first choice
por: Guan, Lili, et al.
Publicado: (2020)

Prediction of noninvasive ventilation failure using the ROX index in patients with de novo acute respiratory failure
por: Duan, Jun, et al.
Publicado: (2022)

ROX index as predictor of high flow nasal cannula therapy success in acute respiratory failure due to SARS-CoV-2
por: Ferrer, Santos, et al.
Publicado: (2021)

Physiological effects of awake prone position in acute hypoxemic respiratory failure
por: Grieco, Domenico Luca, et al.
Publicado: (2023)

Non-invasive ventilatory support and high-flow nasal oxygen as first-line treatment of acute hypoxemic respiratory failure and ARDS
por: Grieco, Domenico Luca, et al.
Publicado: (2021)

The ROX index (Index combining the respiratory rate with oxygenation) is a prognostic factor for acute respiratory distress syndrome
por: Nishiyama, Kenta, et al.
Publicado: (2023)

Evaluation of Oxygen Saturation Index Compared With Oxygenation Index in Neonates With Hypoxemic Respiratory Failure
por: Muniraman, Hemananda K., et al.
Publicado: (2019)

ROX index and SpO(2)/FiO(2) ratio for predicting high-flow nasal cannula failure in hypoxemic COVID-19 patients: A multicenter retrospective study
por: Kim, Jin Hyoung, et al.
Publicado: (2022)

ELMO helmet for CPAP to treat COVID-19-related acute hypoxemic respiratory failure outside the ICU: aspects of/comments on its assembly and methodology
por: Mazza, Mariano, et al.
Publicado: (2022)

The Relationship of Respiratory Rate-Oxygenation (ROX) and Modified ROX Index With High-Flow Nasal Cannula Oxygen Therapy in COVID-19 Patients: An Observational Pilot Study
por: Karim, Habib Md R, et al.
Publicado: (2022)

Sigh in Patients With Acute Hypoxemic Respiratory Failure and ARDS: The PROTECTION Pilot Randomized Clinical Trial
por: Mauri, Tommaso, et al.
Publicado: (2021)

ELMO, a new helmet interface for CPAP to treat COVID-19-related acute hypoxemic respiratory failure outside the ICU: a feasibility study
por: Tomaz, Betina Santos, et al.
Publicado: (2022)

Acute Hypoxemic Respiratory Failure Due to COVID-19 in a Patient With Underlying Lymphangioleiomyomatosis
por: Glowacki, Joseph, et al.
Publicado: (2022)

Hypoxemic Respiratory Failure Due to Alveolar Pulmonary Sarcoidosis Following COVID-19 Infection
por: Mistry, Hemanshi Y, et al.
Publicado: (2023)

The Use of the “Respiratory Rate Oxygenation (ROX) Index” in the Assessment of Respiratory Support and Observation of Its Outcome in COVID-19 Patients With Acute Respiratory Failure
por: Bhuiyan, Abdullah T, et al.
Publicado: (2023)

Predicting Outcomes of High-Flow Nasal Cannula for Acute Respiratory Distress Syndrome. An Index that ROX
por: Hill, Nicholas S., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_eoolbil4jsnrdcva38nml83de5